IMRA logo

IMARA (IMRA) Stock

Profile

Full Name:

IMARA Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

12 March 2020

Indexes:

Not included

Website:

http://imaratx.com

Description:

IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

$0.06(+102.53% YoY)

PE Ratio

-

Annual ROE

1.75%

Annual Debt To Equity

0.00

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

May 05, 2023

Recent annual earnings:

Mar 15, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Feb 24, 2023

Analyst ratings

Recent major analysts updates

06 Apr '22 SVB Leerink
Market Perform
16 Mar '22 SVB Leerink
Outperform
06 Jan '22 Morgan Stanley
Equal-Weight
30 Nov '21 HC Wainwright & Co.
Buy
11 Aug '21 Morgan Stanley
Equal-Weight
19 Apr '21 Morgan Stanley
Overweight
08 Mar '21 SVB Leerink
Outperform
08 Mar '21 Morgan Stanley
Overweight
17 Aug '20 Citigroup
Buy
30 June '20 Citigroup
Neutral

Screeners with IMRA included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price All-time High

$54.87
IMRA price is currently at an all-time high

Price Analysts Target

$1.40
IMRA price is currently equal to the consensus analysts' forecast

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Net Income 3-Year Change

+106.72%
IMRA annual net profit is up +106.72% over the past 3 years

Annual EPS 3-Year Change

+104.17%
IMRA annual earnings per share is up +104.17% over the past 3 years

Annual EPS Estimate

-$0.53
IMRA annual earnings per share is currently -111.32% lower than the consensus analysts' forecast

Annual Operating Profit

-$34.27 M
IMRA annual operaing income is -$34.27 million

Annual Operating Profit 3-Year Change

-42.1%
IMRA annual operaing income is down -42.1% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

1.75%
IMRA annual return on equity is 1.75%

Annual ROA

1.71%
IMRA annual return on assets is 1.71%

Annual EBIT

-$34.27 M
IMRA annual earnings before interest & taxes is -$34.27 million

Annual EBITDA

-$33.66 M
IMRA annual earnings before interest, taxes, depreciation & amortization is -$33.66 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

48.98
IMRA annual current ratio is 48.98

Annual Total Assets

$91.96 M
IMRA annual total assets is $91.96 million

Annual Current Assets

$89.64 M
IMRA annual total current assets is $89.64 million

Annual Total Liabilities

$1.83 M
IMRA annual total liabilities is $1.83 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-62.58%
IMRA annual cash flow from operations is down -62.58% over the past 3 years

Annual CFI 3-Year Change

+418.02%
IMRA annual cash flow from investing activities is up +418.02% over the past 3 years

Annual CFF 3-Year Change

-102.83%
IMRA annual cash flow from financing activities is down -102.83% over the past 3 years

Annual FCF

-$35.93 M
IMRA annual free cash flow is -$35.93 million

Annual FCF 3-Year Change

-63.2%
IMRA annual free cash flow is down -63.2% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of IMARA?
  • What is the ticker symbol for IMARA?
  • Does IMARA pay dividends?
  • What sector is IMARA in?
  • What industry is IMARA in?
  • What country is IMARA based in?
  • When did IMARA go public?
  • Is IMARA in the S&P 500?
  • Is IMARA in the NASDAQ 100?
  • Is IMARA in the Dow Jones?
  • When was IMARA's last earnings report?
  • When does IMARA report earnings?
  • Should I buy IMARA stock now?

What is the primary business of IMARA?

IMARA Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapeutics to treat patients suffering from serious diseases. The company was incorporated in 2016 and is based in Brookline, Massachusetts.

What is the ticker symbol for IMARA?

The ticker symbol for IMARA is NASDAQ:IMRA

Does IMARA pay dividends?

No, IMARA does not pay dividends

What sector is IMARA in?

IMARA is in the Healthcare sector

What industry is IMARA in?

IMARA is in the Biotechnology industry

What country is IMARA based in?

IMARA is headquartered in United States

When did IMARA go public?

IMARA's initial public offering (IPO) was on 12 March 2020

Is IMARA in the S&P 500?

No, IMARA is not included in the S&P 500 index

Is IMARA in the NASDAQ 100?

No, IMARA is not included in the NASDAQ 100 index

Is IMARA in the Dow Jones?

No, IMARA is not included in the Dow Jones index

When was IMARA's last earnings report?

IMARA's most recent earnings report was on 5 May 2023

When does IMARA report earnings?

The date for IMARA's next earnings report has not been announced yet

Should I buy IMARA stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions